BTI 322. Anti-CD2 monoclonal antibody, Lo-CD2-a, monoclonal antibody Lo-CD2-a.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006087:Graft vs Host Reaction / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology
D000911:Antibodies, Monoclonal; D015507:Drugs, Investigational; D007166:Immunosuppressive Agents; C105249:LO-CD2a